Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-12

Clinical Trial Update: Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and efficacy of Omnitrope (rhGH) in children born small for gestational age (SGA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OMNITROPE (somatropin)

Snippet

Sponsor: Sandoz | Conditions: Small for Gestational Age | Phase 4 | Status: COMPLETED | Results posted: 2024-03-12